These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35665026)

  • 1. Immunotherapy Resistance in Non-Small Cell Lung Cancer: A Rubik's Cube to Assemble.
    Rolfo C; Ordóñez-Reyes C; Cardona AF
    J Immunother Precis Oncol; 2021 Nov; 4(4):185-188. PubMed ID: 35665026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learning and Transfer in Problem Solving Progressions.
    Daniels JS; Moreau D; Macnamara BN
    J Intell; 2022 Oct; 10(4):. PubMed ID: 36278607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy.
    Liu D; Badeti S; Dotti G; Jiang JG; Wang H; Dermody J; Soteropoulos P; Streck D; Birge RB; Liu C
    Cell Commun Signal; 2020 Aug; 18(1):134. PubMed ID: 32843053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rubik's microfluidic cube.
    Lai X; Shi Z; Pu Z; Zhang P; Zhang X; Yu H; Li D
    Microsyst Nanoeng; 2020; 6():27. PubMed ID: 34567642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting.
    Reck M; Garassino MC; Imbimbo M; Shepherd FA; Socinski MA; Shih JY; Tsao A; Lee P; Winfree KB; Sashegyi A; Cheng R; Varea R; Levy B; Garon E
    Lung Cancer; 2018 Jun; 120():62-69. PubMed ID: 29748017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.
    Zhang K; Yuan Q
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative beneficiary effects of immunotherapy against chemotherapy in patients with advanced NSCLC: Meta-analysis and systematic review.
    Yu DP; Cheng X; Liu ZD; Xu SF
    Oncol Lett; 2017 Aug; 14(2):1568-1580. PubMed ID: 28789381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy.
    Shao C; Yang M; Pan Y; Xie D; Chen B; Ren S; Zhou C
    Front Immunol; 2021; 12():696749. PubMed ID: 34413851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which treatment after first line therapy in NSCLC patients without genetic alterations in the era of immunotherapy?
    Insa A; Martín-Martorell P; Di Liello R; Fasano M; Martini G; Napolitano S; Vicidomini G; Cappabianca S; Franco R; Morgillo F; Della Corte CM
    Crit Rev Oncol Hematol; 2022 Jan; 169():103538. PubMed ID: 34801700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
    Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
    Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy.
    Adam LC; Raja J; Ludwig JM; Adeniran A; Gettinger SN; Kim HS
    J Immunother Cancer; 2018 Dec; 6(1):147. PubMed ID: 30541627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy in non-small cell lung cancer patients: back to the future.].
    Roberto M; Botticelli A; Cecere F; Cognetti F; Giusti R; Gelibter A; Lugini A; Nelli F; Nuti M; Santini D; Marchetti P
    Recenti Prog Med; 2019 Dec; 110(12):587-593. PubMed ID: 31909761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression Patterns, Treatment, and Prognosis Beyond Resistance of Responders to Immunotherapy in Advanced Non-Small Cell Lung Cancer.
    Xu Y; Li H; Fan Y
    Front Oncol; 2021; 11():642883. PubMed ID: 33747966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rubik's Cube+: A self-supervised feature learning framework for 3D medical image analysis.
    Zhu J; Li Y; Hu Y; Ma K; Zhou SK; Zheng Y
    Med Image Anal; 2020 Aug; 64():101746. PubMed ID: 32544840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer.
    Waterhouse D; Lam J; Betts KA; Yin L; Gao S; Yuan Y; Hartman J; Rao S; Lubinga S; Stenehjem D
    Lung Cancer; 2021 Jun; 156():41-49. PubMed ID: 33894493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: a systematic review.
    Li L; Xu F; Chen Y; Ren X; Liu Y; Chen Y; Xia S
    BMJ Open; 2020 Nov; 10(11):e034010. PubMed ID: 33444168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
    Imakita T; Fujita K; Kanai O; Okamura M; Hashimoto M; Nakatani K; Sawai S; Mio T
    Thorac Cancer; 2021 Nov; 12(22):3062-3067. PubMed ID: 34622569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy.
    Mielgo-Rubio X; Montemuiño S; Jiménez U; Luna J; Cardeña A; Mezquita L; Martín M; Couñago F
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure.
    Pathak R; Pharaon RR; Mohanty A; Villaflor VM; Salgia R; Massarelli E
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33419311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
    Min HY; Lee HY
    Arch Pharm Res; 2021 Feb; 44(2):146-164. PubMed ID: 33608812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.